OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP. Share Price

Certificat

DE000GG2LWV8

Real-time BOERSE MUENCHEN 11:57:01 23/05/2024 pm IST
4.17 EUR +6.92% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP.
Current month+4.56%
1 month-14.47%
Date Price Change
23/24/23 4.17 +6.92%
22/24/22 3.9 -10.34%
21/24/21 4.35 +1.87%
20/24/20 4.27 +4.66%
17/24/17 4.08 +3.03%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 11:57 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG2LWV
ISINDE000GG2LWV8
Date issued 16/01/2024
Strike 376.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.79
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.28
Lowest since issue 1.61
Spread 0.03
Spread %0.76%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.4 USD
Average target price
372.4 USD
Spread / Average Target
+11.01%
Consensus